Table 7
Survival and combination of CD34 and tumour invasion in patients with NSCLC
Groups
Median survival (months)
95% CI
p Value
CI, confidence interval; NSCLC, non-small cell lung cancer; TVI, tumour vessel invasion.
A (CD34+/TVI+)
15
7 to 23
<0.0001
B (CD34−/TVI+, CD34+/TVI−)
44
6 to 82
C (CD34−/TVI−)
116
84 to 148